Your browser doesn't support javascript.
loading
Acral cutaneous metastasis from a primary breast carcinoma following chemotherapy with bevacizumab and paclitaxel.
Armstrong, Patrick; Woody, Meghan M; Reichenberg, Jason S; Gavino, Alde Cp.
Afiliação
  • Armstrong P; Department of Dermatology, University of California, Los Angeles, USA.
  • Woody MM; Department of Dermatology, Oregon Health + Sciences University, Portland, USA.
  • Reichenberg JS; Department of Dermatology, University of Texas, Dell Medical School, Austin, USA.
  • Gavino AC; Tru-Skin Dermatology, Cedar Park, Texas, USA.
Cutis ; 102(3): E12-E14, 2018 Sep.
Article em En | MEDLINE | ID: mdl-30372726
ABSTRACT
Acral cutaneous metastasis from internal malignancy is rare, and the pathogenesis is not completely understood. We present the case of a 54-year-old black woman with a history of breast cancer diagnosed 2 years prior who developed multiple cutaneous metastases to acral sites involving the palmar and plantar surfaces of the hands and feet. This case represents an unusual metastatic pattern of breast carcinoma that arose after treatment with bevacizumab, an angiogenesis inhibitor that binds vascular endothelial growth factor A. We propose that bevacizumab-induced vascular changes localized to acral skin may have contributed to the metastatic pattern seen in our patient.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Bevacizumab Limite: Female / Humans / Middle aged Idioma: En Revista: Cutis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Bevacizumab Limite: Female / Humans / Middle aged Idioma: En Revista: Cutis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos